India is planning the second phase of its semiconductor incentive scheme, DLI 2.0. Concerns are rising among domestic startups that allowin...

The new refrigerants called hydrofluoroolefins, or HFOs, are quickly replacing older hydrofluorocarbons, or HFCs, in the USA and Europe as ...

Tesla has reportedly saved over 400 million dollars on US taxes. This was achieved through a financial maneuver involving its units in the ...

Indian drug maker Sun Pharma faces significant exposure to potential US tariffs on medicines. Global brokerage Jefferies warns that while g...

As per the suit, the Pune-based company said Royal Enfield has infringed its patent on 'Regulator Rectifier Device' and method for regulati...

In a statement to ET, Roche said it welcomed the decision of the court, which has upheld the patent covering erlotinib hydrochloride.

Venus Remedies will start selling its pain reliever 'Trois' in the Singapore market and is expecting a revenue of $10 million.

India is now in the position of a thought leader on pharmaceutical patents. But the country cannot afford to lose the moral high ground.

Patents appeal board has dismissed AstraZeneca's petition challenging an earlier ruling that refused patent protection for a cancer-fightin...

It would safeguard India's ability to export drugs made under compulsory licences issued by a third country.

Shares of Suven Life Sciences gained around 5% after the company secured four overseas product patents.

Chip maker Qualcomm Inc. said on late Sunday it will pay Broadcom Corp. $891 mn over four years to settle a longstanding dispute over paten...

With the global pharmaceutical market likely to witness products worth 123 billion dollars loosing patents by 2012, the generics driven Ind...

Company's co-founder, Kalyan Kankanala, foresees a six-fold rise in activities related to patent-management this fiscal. The selling mantra

The US Supreme Court has ruled that AT&T could not extend its patent complaint with Microsoft past US borders in a welcomed precedent for U...

Microsoft, backed by the US government and heavyweight corporations, has taken its patent battle with telecommunications giant AT and T to ...

This one’s a pop out for pharma. Revenues from new product launches in the pharma sector fell 48% to Rs 224.2 crore in ’05.